High efficiency of the pan-PI3K/mTOR inhibitor, PQR-309, in MCL

被引：0
|
作者：
Kvint, R. [1 ]
Zimmermann, Y. [1 ]
Hutter, G. [1 ]
Hiddemann, W. [1 ]
Dreyling, M. [1 ]
机构：
[1] Klinikum Univ Munchen, Med Klin 3, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P524
引用
收藏
页码：153 / 154
页数：2
相关论文
共 50 条
  • [41] A phase 1 study of the PI3K/mTOR inhibitor PQR309 evaluating safety, pharmacokinetics (PK) and pharmacodynamics (PD) in patients (pts) with advanced solid tumors.
    Adjei, Alex A.
    Dy, Grace K.
    Zhao, Yujie
    Ma, Wen Wee
    Opyrchal, Mateusz
    Bakhribah, Hatoon
    Jacob, Sandra M.
    O'Hara, Corrie
    Dozier, Askia
    Cmiljanovic, Natasa
    Todaro, Barbara
    Brady, William E.
    Schmitz, Debora
    Dimitrijevic, Sasa
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Hyperglycemia in patients treated with the pan-PI3K inhibitor buparlisib (BKM120): characterization, management, and assessment for pharmacodynamics
    Azaro, A.
    Rodon, J.
    Vansteenkiste, J. F.
    Ando, Y.
    Doi, T.
    Mills, D.
    Sarr, C.
    Di Tomaso, E.
    Massacesi, C.
    Naumann, R. W.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S186 - S186
  • [43] PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma
    Cao, Jiaxin
    Zeng, Kangmei
    Chen, Qun
    Yang, Ting
    Lu, Feiteng
    Lin, Chaozhuo
    Zhan, Jianhua
    Ma, Wenjuan
    Zhou, Ting
    Huang, Yan
    Luo, Fan
    Zhao, Hongyun
    CELL DEATH & DISEASE, 2024, 15 (03)
  • [44] A novel Pan-PI3K/Akt inhibitor, SF1126, inhibits in vitro growth of multiple myeloma cells
    Silberman, Jeannine
    Dalbey, Kimberly
    Torre, Claire
    David, Ebenezer
    Bergsagel, Leif
    Durden, Donald
    Garlich, Joseph
    Schwertschlag, Ulrich
    Lonial, Sagar
    BLOOD, 2007, 110 (11) : 275B - 275B
  • [45] EFFICACY OF THE PAN PI3K-INHIBITOR COPANLISIB COMPARED TO SELECTIVE PI3K-A, -B, -Δ INHIBITORS IN MANTLE CELL LYMPHOMA (MCL)
    Zoellner, A.
    Arnd, J.
    Hutter, G.
    Zimmermann, Y.
    Hiddemann, W.
    Dreyling, M.
    HAEMATOLOGICA, 2015, 100 : 551 - 551
  • [46] Omipalisib (GSK458), a dual pan-PI3K/mTOR inhibitor, exhibits in vitro and in vivo activity in chemotherapy-sensitive and -resistant models of Burkitt lymphoma
    Ippolito, Thomas
    Tang, Greg
    Mavis, Cory
    Gu, Juan
    Hernandez-Illizaliturri, Francisco
    Barth, Matthew J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 38 - 38
  • [47] Clinical and histologic characterization of dermatologic adverse events front the pan-PI3K inhibitor buparlisib (BKM-120)
    Schindler, Katja
    Abraham, Ronnie
    Shah, Payal Deepak
    Chandarlapaty, Sarat
    Palk, Paul K.
    Bell-McGuinn, Katherine
    Bajorin, Dean F.
    Mellinghoff, Ingo K.
    Younes, Anas
    Gounder, Mrinal M.
    Fury, Matthew G.
    Busam, Klaus J.
    Dickler, Maura N.
    Lacouture, Mario E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] PQR309, a dual PI3K/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3β and STAT3/HSP60 signaling pathways to treat nasopharyngeal carcinoma
    Jiaxin Cao
    Kangmei Zeng
    Qun Chen
    Ting Yang
    Feiteng Lu
    Chaozhuo Lin
    Jianhua Zhan
    Wenjuan Ma
    Ting Zhou
    Yan Huang
    Fan Luo
    Hongyun Zhao
    Cell Death & Disease, 15
  • [49] Effect of combined treatment with a pan-PI3K inhibitor or an isoform-specific PI3K inhibitor and everolimus on cell proliferation in GH-secreting pituitary tumour in an experimental setting
    Claudia Pivonello
    Roberta Patalano
    Domenico Solari
    Renata S. Auriemma
    Federico Frio
    Francesca Vitulli
    Ludovica F. S. Grasso
    Marialuisa Di Cera
    Maria Cristina De Martino
    Luigi M. Cavallo
    Paolo Cappabianca
    Annamaria Colao
    Rosario Pivonello
    Endocrine, 2018, 62 : 663 - 680
  • [50] PI3K/mTORC1/2 inhibitor PQR309 inhibits proliferation and induces apoptosis in human glioblastoma cells
    Yang, Kun
    Tang, Xiang-Jun
    Xu, Feng-Fei
    Liu, Jun-Hui
    Tan, Yin-Qiu
    Gao, Lun
    Sun, Qian
    Ding, Xiang
    Liu, Bao-Hui
    Chen, Qian-Xue
    ONCOLOGY REPORTS, 2020, 43 (03) : 773 - 782
12345